$82.16 +1.64 (2.037%) Synageva BioPharma Corp - NASDAQ

Nov. 26, 2014 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
10/30/2014BOESS CARSTENSVP, Chief Financial Officer-22,904$80.11-100.00%
10/30/2014BOESS CARSTENSVP, Chief Financial Officer7,854$23.0052.19%
10/28/2014BOESS CARSTENSVP, Chief Financial Officer-1,500$80.00-60.00%
10/28/2014BOESS CARSTENSVP, Chief Financial Officer1,000$23.0066.67%
10/28/2014BOESS CARSTENSVP, Chief Financial Officer-1,000$80.00-100.00%
9/19/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy-790$65.24-58.43%
9/19/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy790$8.73140.57%
9/17/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy-4,200$65.06-88.20%
9/17/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy4,200$8.73747.33%
9/16/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy-9,379$65.01-94.35%
9/16/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy9,379$8.731,668.86%
9/02/2014Quinn AnthonyEVP, CMO & Head of R&D-300$72.88-1.16%
9/02/2014Quinn AnthonyEVP, CMO & Head of R&D-700$71.96-2.63%
9/02/2014Quinn AnthonyEVP, CMO & Head of R&D-400$70.50-1.48%
9/02/2014Quinn AnthonyEVP, CMO & Head of R&D-8,600$69.88-24.16%
9/02/2014Quinn AnthonyEVP, CMO & Head of R&D10,000$23.0039.07%
6/30/2014Heberlig ChrisGroup Vice President, Finance112$54.8958.33%
6/30/2014Quinn AnthonyEVP, CMO & Head of R&D71$54.890.28%
6/30/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy103$54.8922.44%
6/30/2014Williams GlenSVP, Technical Operations117$54.8943.98%
6/25/2014Williams GlenSVP, Technical Operations-700$108.02-72.46%
6/25/2014Williams GlenSVP, Technical Operations400$57.5670.67%
6/25/2014Williams GlenSVP, Technical Operations300$40.32112.78%
6/20/2014Quart Barry DDirector-1,375$100.00-100.00%
6/20/2014BAKER FELIXSenior Executive Officer4,250$60.451.94%
6/17/2014Quart Barry DDirector-1,000$90.00-100.00%
6/12/2014Quart Barry DDirector-1,000$83.31-100.00%
6/11/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy1,926$0.95419.61%
6/11/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy18,637$8.73781.43%
6/11/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy1,034$0.954.92%
6/11/2014Goldberg Mark AlanEVP, Medical & Reg. Strategy-21,597$80.00-97.92%
5/16/2014BOESS CARSTENSVP, Chief Financial Officer-8,136$81.75-81.96%
5/16/2014BOESS CARSTENSVP, Chief Financial Officer-1,591$82.71-88.83%
5/16/2014BOESS CARSTENSVP, Chief Financial Officer-200$83.46-100.00%
4/23/2014BAKER FELIXSenior Executive Officer8,000$65.100.46%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D10,000$0.9564.42%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D10,000$23.0039.18%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D-10,675$82.80-30.05%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D-4,746$84.72-22.26%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D-1,050$85.76-6.34%
4/01/2014Quinn AnthonyEVP, CMO & Head of R&D-3,529$83.50-14.20%
3/12/2014Heberlig ChrisGroup Vice President, Finance820$0.9540.16%
3/12/2014Heberlig ChrisGroup Vice President, Finance1,850$1.70963.54%
3/12/2014Heberlig ChrisGroup Vice President, Finance5,000$23.00174.70%
3/12/2014Heberlig ChrisGroup Vice President, Finance-700$96.75-8.90%
3/12/2014Heberlig ChrisGroup Vice President, Finance-3,933$98.49-54.91%
3/12/2014Heberlig ChrisGroup Vice President, Finance-3,037$99.08-94.05%
3/06/2014BAKER JULIANSenior Executive Officer9,031$105.754.46%
3/06/2014BAKER JULIANSenior Executive Officer365,969$105.754.69%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-894$104.22-100.00%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-1,745$103.05-66.12%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-3,207$102.18-54.86%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-3,081$101.14-34.51%
2/18/2014BOESS CARSTENSVP, Chief Financial Officer-1,000$100.07-10.07%
1/29/2014Patel Sanj KPresident & CEO-24,817$87.19-47.72%
1/29/2014Patel Sanj KPresident & CEO-18,652$88.31-68.61%
1/29/2014Patel Sanj KPresident & CEO-5,600$89.27-65.63%
1/29/2014Patel Sanj KPresident & CEO-1,502$90.85-51.21%
1/29/2014Patel Sanj KPresident & CEO-400$91.58-27.95%
1/29/2014Patel Sanj KPresident & CEO50,971$3.524,943.84%
1/28/2014Patel Sanj KPresident & CEO24,832$3.52347.93%
1/28/2014Patel Sanj KPresident & CEO20,391$1.7063.78%
1/28/2014Patel Sanj KPresident & CEO-9,506$87.16-18.16%
1/28/2014Patel Sanj KPresident & CEO-32,609$88.38-76.09%
1/28/2014Patel Sanj KPresident & CEO-8,402$88.95-82.01%
1/28/2014Patel Sanj KPresident & CEO-812$90.10-44.06%
1/28/2014Patel Sanj KPresident & CEO6,106$0.95592.24%
12/31/2013Quinn AnthonyEVP, CMO & Head of R&D192$36.301.25%
12/31/2013Williams GlenSVP, Technical Operations132$36.3098.51%
12/31/2013Goldberg Mark AlanEVP, Medical & Reg. Strategy192$36.3071.91%
12/03/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-413$61.02-60.74%
12/03/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-6,587$60.49-90.64%
12/02/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-3,861$53.98-38.89%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-1,765$54.97-29.10%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-3,801$55.99-88.37%
11/18/2013BOESS CARSTENSVP, Chief Financial Officer-500$57.20-100.00%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-100$51.04-27.25%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,695$49.61-50.85%
11/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,205$50.34-89.73%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,770$64.61-93.39%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs-3,230$63.97-44.45%
10/01/2013Goldberg Mark AlanSVP,Medical&Regulatory Affairs7,000$8.732,621.72%
9/25/2013BAKER FELIXSenior Executive Officer25,663$56.6314.51%
9/25/2013BAKER FELIXSenior Executive Officer1,024,337$56.6315.10%
8/21/2013BOESS CARSTENSVP, Chief Financial Officer-6,681$47.19-100.00%
8/20/2013BOESS CARSTENSVP, Chief Financial Officer2,173$23.0038.62%
8/20/2013BOESS CARSTENSVP, Chief Financial Officer-7,800$47.04-100.00%
8/16/2013BOESS CARSTENSVP, Chief Financial Officer-4,300$47.47-100.00%
7/29/2013Patel Sanj KPresident & CEO-15,895$47.39-93.91%
7/29/2013Patel Sanj KPresident & CEO15,895$3.521,541.71%
7/26/2013Patel Sanj KPresident & CEO-17,204$48.31-94.35%
7/26/2013Patel Sanj KPresident & CEO35,308$3.52193.63%
7/26/2013Patel Sanj KPresident & CEO-52,190$47.91-74.11%
7/26/2013Patel Sanj KPresident & CEO16,882$1.7031.53%
7/25/2013Patel Sanj KPresident & CEO8,251$0.95800.29%
7/25/2013Patel Sanj KPresident & CEO-14,711$48.73-44.65%
7/25/2013Patel Sanj KPresident & CEO3,664$0.9539.47%
7/25/2013Patel Sanj KPresident & CEO20,000$1.70154.49%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (GEVA), click here.
  • Showing 1-100 of 243 items
  • 1
  • 2
  • 3
  • >>
Trading Center